Clinical Trial Update: Cetuximab-IRDye 800CW and Intraoperative Imaging in Finding Pancreatic Cancer in Patients Undergoing Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial investigating Cetuximab-IRDye 800CW for intraoperative imaging to locate pancreatic cancer during surgery; study terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Drugs mentioned

• Cetuximab-IRDye 800CW

Snippet

Sponsor: Eben Rosenthal | Conditions: Pancreatic Adenocarcinoma | Phase 2 | Status: TERMINATED | Results posted: 2019-02-01